AChE-IN-7 is a selective and potent acetylcholinesterase (AChE) inhibitor with potential therapeutic applications in conditions involving cholinergic dysfunction, such as Alzheimer's disease; it exhibits high blood-brain barrier (BBB) permeability, favorable pharmacokinetic properties, and high oral bioavailability (F = 55.5%).